Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

被引：0
|
作者：
David M. G. Halpin
Marjan Kerkhof
Joan B. Soriano
Helga Mikkelsen
David B. Price
机构：
[1] Royal Devon & Exeter Hospital,Department of Respiratory Medicine
[2] Research in Real-Life Ltd,Instituto de Investigación Hospital Universitario de la Princesa (IISP)
[3] Universidad Autónoma de Madrid,Academic Primary Care, Division of Applied Health Sciences
[4] Cátedra UAM-Linde,undefined
[5] Cambridge Research Support Ltd,undefined
[6] University of Aberdeen,undefined
来源：
Respiratory Research | / 17卷
关键词：
Randomised controlled trial; Real-life research; Chronic obstructive pulmonary disease; Long-acting bronchodilator;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Bronchodilator Response To The Long-Acting Bronchodilator Combination Of Umeclidinium/vilanterol Across Subgroups Of Patients With COPD
    Han, M. K.
    Kalberg, C.
    Brooks, J.
    Church, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [22] Residual reversibility in COPD patients already on long-acting bronchodilator: The OscilloRevers Study
    Le Rouzic, Olivier
    Picaud, Marjorie
    Salvator, Helene
    Bautin, Nathalie
    Devillier, Philippe
    Perez, Thierry
    RESPIRATORY MEDICINE AND RESEARCH, 2024, 85
  • [23] Persistence to inhaled long-acting maintenance therapy in patients with COPD in UK routine clinical practice
    Rothnie, Kieran J.
    Wood, Robert P.
    Numbere, Beade
    Seif, Monica
    Requena, Gema
    Diomatari, Christina
    Goodall, Emma C.
    Noorduyn, Stephen G.
    Cooper, Charley
    Sharma, Raj
    Compton, Chris
    Ismaila, Afisi S.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [24] The role of combination inhaled corticosteroid/long-acting β-agonist therapy in COPD management
    Mapel, Douglas W.
    Hurley, Judith S.
    Dalal, Anand A.
    Blanchette, Christopher M.
    PRIMARY CARE RESPIRATORY JOURNAL, 2010, 19 (02): : 93 - 103
  • [25] Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD
    McNicholas, WT
    Calverley, PMA
    Lee, A
    Edwards, JC
    EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) : 825 - 831
  • [26] The impact of inhaled corticosteroid and long-acting β-agonist combination therapy on outcomes in COPD
    Hanania, Nicola A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (03) : 540 - 550
  • [27] Real-Life Prescribing And Outcomes Of Long-Acting Anticholinergic Therapy In Adult Asthma Patients In Uk Clinical Practice
    Price, D. B.
    Kaplan, A.
    Jones, R.
    Freeman, D.
    Burden, A.
    Gould, S. E.
    West, D.
    Thomas, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [28] An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naive Patients With COPD
    Singh, Dave
    D'Urzo, Anthony D.
    Donohue, James F.
    Kerwin, Edward M.
    Molins, Eduard
    Chuecos, Ferran
    Ribera, Anna
    Jarreta, Diana
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 2835 - 2848
  • [29] Tailoring the long-acting GH therapy in the real life
    Mozzato, Chiara
    Zoletto, Silvia
    Meneghin, Alice
    Guazzarotti, Laura
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 237 - 237
  • [30] Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma?
    Currie, GP
    Lee, DKC
    Srivastava, P
    CHEST, 2005, 128 (04) : 2954 - 2962
12345